REPORT OF THE COMMITTEE
Thursday, December 12, 2013
The Standing SenateCommittee on Social Affairs, Science and Technology has the honour to present its
Your committee, which was authorized by the Senate on Tuesday, November 19, 2013 to examine and report on prescription pharmaceuticals in Canada, respectfully requests funds for the fiscal year ending March 31, 2014, and requests, for the purpose of such study, that it be empowered to engage the services of such counsel, technical, clerical and other personnel as may be necessary.
Pursuant to Chapter 3:06, section 2(1)(c) of the Senate Administrative Rules, the budget submitted to the Standing Committee on Internal Economy, Budgets and Administration and the report thereon of that committee are appended to this report.
KELVIN K. OGILVIE
STANDING SENATE COMMITTEE ON
SOCIAL AFFAIRS, SCIENCE AND TECHNOLOGY
SPECIAL STUDY ON PRESCRIPTION PHARMACEUTICALS IN CANADA
APPLICATION FOR BUDGET AUTHORIZATION
FOR THE FISCAL YEAR ENDING MARCH 31, 2014
Extract from the Journals of the Senate, Tuesday, November 19, 2013:
The Honourable Senator Ogilvie moved, seconded by the Honourable Senator Runciman:
That the Standing Senate Committee on Social Affairs, Science and Technology be authorized to examine and report on prescription pharmaceuticals in Canada, including but not limited to:
(a) the process to approve prescription pharmaceuticals with a particular focus on clinical trials;
(b) the post-approval monitoring of prescription pharmaceuticals;
(c) the off-label use of prescription pharmaceuticals; and
(d) the nature of unintended consequences in the use of prescription pharmaceuticals.
That the papers and evidence received and taken and work accomplished by the committee on this subject during the First Session of the Forty-first Parliament be referred to the committee; and
That the committee submit its final report no later than December 31, 2014 and that the committee retain until March 31, 2015, all powers necessary to publicize its findings.
The question being put on the motion, it was adopted.
Gary W. O’Brien
Clerk of the Senate
APPENDIX (B) TO THE REPORT
THURSDAY, December 12, 2013
The Standing Committee on Internal Economy, Budgets and Administration has examined the budget presented to it by the Standing Senate Committee on Social Affairs, Science and Technology for the proposed expenditures of the said Committee for the fiscal year ending March 31, 2014, for the purpose of its special study on prescription pharmaceuticals, as authorized by the Senate on Tuesday, November 19, 2013. The said budget is as follows:
General Expenses $15,300
NOËL A. KINSELLA